Menu
Recruiting NCT06848959

Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models

— Observational Cerebral Palsy Mental Retardation Tourette's Syndrome Attention Deficit Hyperactivity Disorder

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: No intervention.
Who it may be relevant to
Registry conditions: Cerebral Palsy, Mental Retardation, Tourette's Syndrome, Attention Deficit Hyperactivity Disorder. Basic parameters: 2 years — 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Jiangsu Provincial Hospital of Traditional Chinese Medicine

Overview

Using the knowledge graph and big model technology of combining Chinese and Western medicine we construct a popularization and prevention system for childhood encephalopathy an assisted decision-making system for childhood encephalopathy and a follow-up tracking question and answer system for childhood encephalopathy patients.

Interventions

  • Other No intervention
    Pediatric Encephalopathy Science and Prevention Decision Aid Follow-Up Q\&A

Primary outcome measures

  • Childhood Autism Rating Scale [Time frame: 4 mouths]
  • meridian and acupointological features [Time frame: 4 mouths]
  • Yale Global Tic Severity Scale [Time frame: 4 mouths]
  • Gross Motor Function Assessment Scale (GMFM)-88 [Time frame: 4 mouths]
  • Autism Behavior Checklist [Time frame: 4 mouths]
  • acupuncture point status [Time frame: 4 mouths]
  • Tongue texture [Time frame: 4 mouths]
  • Wechsler intelligence scale (WIS) [Time frame: 4 mouths]
  • Resting heart rate [Time frame: 4 mouths]
  • blood pressure (systolic, diastolic) after 10 minutes of rest [Time frame: 4 mouths]
Secondary outcome measures (4)
  • Saliva [Time frame: 4 mouths]
  • blood [Time frame: 4 mouths]
  • Urine [Time frame: 4 mouths]
  • Faeces [Time frame: 4 mouths]

Eligibility criteria

Inclusion criteria

  • 1\. meet diagnostic criteria for CP ID TD ADHD ASD; 2. gender is not limited;

Exclusion criteria

  • 1\. CP ID TD ASD due to chorea hepatomegaly hearing abnormality and pharmacogenetic factors;
  • 2\. Children with other major mental illnesses (e.g. schizophrenia) or organic diseases (e.g. congenital heart disease);

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

China · 1 center
  • Jiangsu Provincial Hospital of Traditional Chinese Medicine — Nanjing

Identifiers

NCT: NCT06848959 · HospitalNanjingU · Nanjing Science and Technology

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗